Skip to main content

First two patients at SurgOne Foregut Institute implanted in EndoStim’s LESS GERD clinical trial for gastroesophageal reflux disease (GERD)

ENGLEWOOD, Colo. and DALLAS, Dec. 1, 2016 /PRNewswire/ – SurgOne Foregut Institute and EndoStim, Inc., announced that the first two patients in Englewood, CO have been implanted with the EndoStim device in the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial, at SurgOne Foregut Institute. The EndoStim system is a minimally-invasive implantable device designed to provide long-term reflux control by restoring normal function to the esophagus through neurostimulation.
http://www.prnewswire.com/news-releases/first-two-patients-at-surgone-foregut-institute-implanted-in-endostims-less-gerd-clinical-trial-for-gastroesophageal-reflux-disease-gerd-300371205.html

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino